Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 22:2020:2575710.
doi: 10.1155/2020/2575710. eCollection 2020.

Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI

Affiliations

Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI

Lu Chen et al. Int J Endocrinol. .

Abstract

Background: Accurate staging of patients with thyroid-associated ophthalmopathy (TAO) is crucial for clinical decision. Full cognition of pathologic changes and staging TAO using conventional T2-weighted imaging is still limited.

Purpose: To investigate the feasibility of using T1 mapping to evaluate changes of extraocular muscles (EOMs) in TAO patients, as well as to compare T1 mapping and conventional T2-weighted imaging in staging TAO.

Materials and methods: Forty TAO patients were retrospectively enrolled. "Hot spot" and "cold spot" T1 relaxation times (T1RTHS and T1RTCS) of EOMs, as well as conventionally applied highest signal intensity ratio (SIR) of EOMs, were measured and compared between active and inactive groups.

Results: T1RTCS and SIR were significantly higher in active TAOs than in the inactive ones (P < 0.001), while T1RTHS was not (P=0.093). Meanwhile, T1RTCS and SIR were positively correlated with clinical activity score (r = 0.489, 0.540; P < 0.001). TIRTCS and SIR showed no significant area under curve for staging TAO (0.830 vs. 0.852; P=0.748). T1RTCS ≥ 1000 alone showed optimal staging specificity (90.0%), while integration of T1RTCS ≥ 1000 and SIR ≥ 2.9 demonstrated optimal staging efficiency and sensitivity (area under curve, 0.900; sensitivity, 86.0%).

Conclusions: Our findings suggest that the T1-mapping technique holds the potency to be utilized in TAO. The derived T1RTCS of EOMs, which may be associated with fat infiltration, could be a useful biomarker to stage the disease, serving added efficiency, sensitivity, and specificity to single usage of conventional SIR.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Methods for measurements of T1RTHS, T1RTCS, and SIR: coronal T1 mapping (a) and coronal fat-suppressed T2-weighted imaging (b) in a 52-year-old male with active TAO. Two circular regions of interest measuring 5–10 mm2 were placed in the area with the highest (white) and lowest (black) signal intensity by naked eye, representing T1RTHS and T1RTCS, respectively (a). Meanwhile, two similar-sized regions of interest were manually placed in the area of the most inflamed EOM with the highest signal intensity as well as ipsilateral temporal muscle (b). T1RTHS, T1RTCS, and SIR values of the left/right eye were 2426/2006 ms, 1365/1422 ms, and 4.14/3.95, respectively. T1RT = T1 relaxation time; HS = hot spot; CS = cold spot; SIR = signal intensity ratio; TAO = thyroid-associated ophthalmopathy.
Figure 2
Figure 2
Box-plot showing the comparisons of T1RT values and SIR between groups. An asterisk indicates a significant difference (P < 0.001).
Figure 3
Figure 3
Receiver operating characteristic curves of significant parameters for staging TAO.
Figure 4
Figure 4
A 33-year-old male with active TAO (a, b) and a 54-year-old female with inactive TAO (c, d) were presented. Taken the left eye for example, the values of T1RTHS, T1RTCS, and SIR were 2282 ms, 1340 ms, and 3.27 for the patient with active TAO (a, b) and 2166 ms, 1062 ms, and 1.62 for the patient with inactive TAO, respectively (c, d).

Similar articles

Cited by

References

    1. Kendler D. L., Lippa J., Rootman J. The initial clinical characteristics of graves’ orbitopathy vary with age and sex. Archives of Ophthalmology. 1993;111(2):197–201. doi: 10.1001/archopht.1993.01090020051022. - DOI - PubMed
    1. Bartalena L., Tanda M. L. Graves’ ophthalmopathy. New England Journal of Medicine. 2009;360(10):994–1001. doi: 10.1056/nejmcp0806317. - DOI - PubMed
    1. Parmar H., Ibrahim M. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimaging Clinics of North America. 2008;18(3):527–536. doi: 10.1016/j.nic.2008.03.003. - DOI - PubMed
    1. Sahlı E., Gunduz K. Thyroid-associated ophthalmopathy. Turkish Journal of Ophthalmology. 2017;47:94–105. - PMC - PubMed
    1. Gilbard J. P., Farris R. L. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmologica. 1983;61(1):108–116. doi: 10.1111/j.1755-3768.1983.tb01401.x. - DOI - PubMed

LinkOut - more resources